摘要
背景:克罗恩病(CD)和溃疡性结肠炎(UC)的诊断和疾病过程中的疾病表型在患者中表现出显着的异质性。 目的:本综述旨在总结当前临床和一些环境预测因素的临床证据,临床医师应该在日常实践中与其他实验室和影像学数据一起评估,以预防疾病进展,实现更个性化的治疗并避免负面的疾病结局。 结果:在最近的基于人群的流行病学和转诊队列研究中,CD和UC的疾病表型的演变显着不同。随访期间,大多数CD和重度UC患者仍需要住院或手术/结肠切除术。怀疑炎症性肠病(IBD)的自然病程有所改变,同时伴随着侵袭性免疫调节剂和生物治疗的定制定位并行的改善。 结论:根据目前可用的文献,尽可能早在疾病过程中尽早提及IBD病例有发生不良疾病风险的风险
关键词: 溃疡性结肠炎,克罗恩病,预测,结果,个体化治疗,炎症性肠病。
图形摘要
Current Drug Targets
Title:Can we Predict Disease Course with Clinical Factors?
Volume: 19 Issue: 7
关键词: 溃疡性结肠炎,克罗恩病,预测,结果,个体化治疗,炎症性肠病。
摘要: Background: The disease phenotype at diagnosis and the disease course of Crohn's disease (CD) and ulcerative colitis (UC) show remarkable heterogeneity across patients.
Objective: This review aims to summarize the currently available evidence on clinical and some environmental predictive factors, which clinicians should evaluate in the everyday practice together with other laboratory and imaging data to prevent disease progression, enable a more personalized therapy, and avoid negative disease outcomes.
Results: In recent population-based epidemiological and referral cohort studies, the evolution of disease phenotype of CD and UC varied significantly. Most CD and severe UC patients still require hospitalization or surgery/colectomy during follow-up. A change in the natural history of inflammatory bowel diseases (IBD) with improved outcomes in parallel with tailored positioning of aggressive immunomodulator and biological therapy has been suspected.
Conclusion: According to the currently available literature, it is of major importance to refer IBD cases at risk for adverse disease outcomes as early during the disease course as possible.
Export Options
About this article
Cite this article as:
Can we Predict Disease Course with Clinical Factors?, Current Drug Targets 2018; 19 (7) . https://dx.doi.org/10.2174/1389450118666170329095123
DOI https://dx.doi.org/10.2174/1389450118666170329095123 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers